Drug Topics

AUGUST 11, 2024

In case you missed it, this week we had news about opioid prescribing for patients with chronic pain, a possible link between cannabis and cancer, preparing for the upcoming flu season, and more.

453

453

STAT

AUGUST 11, 2024

The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels of the Food and Drug Administration’s rejection of the closely watched treatment for post-traumatic stress disorder. Many authors on the three studies are affiliated with the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and its commercial spinout Lykos Therapeutics, including founder Rick Doblin, who spearheaded the decades-long efforts to win a

145

145

Pharmacy Times

AUGUST 11, 2024

The use of CGMs in pregnancy provides clinicians with essential data in real-time, rather than a snapshot given by traditional finger stick testing.

132

132

STAT

AUGUST 11, 2024

The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a psychedelic drug known on the street as Ecstasy or molly) plus therapy for post-traumatic stress disorder comes as no surprise, given an advisory panel’s “no” vote on the application in June. But if lessons from reproductive health are any signal, I believe there is a future for psychedelics in health care.

FDA 133

FDA 133

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Med Ed 101

AUGUST 11, 2024

Benazepril and lisinopril are both ACE Inhibitors that are commonly used in practice. Lisinopril is the most frequently used ACE inhibitor. In this article, we will compare benazepril versus lisinopril and highlight some of the differences that may help guide the selection of one versus the other. Angiotensin-converting enzyme (ACE) inhibitors are a specific medication […] The post Benazepril Versus Lisinopril appeared first on Med Ed 101.

105

105

STAT

AUGUST 11, 2024

As a global health investor and public health advocate, I understand the benefit of weight loss drugs and the rush to promote Ozempic, Wegovy, and other GLP-1 drugs. What I cannot wrap my head around is how, almost 45 years after the World Health Organization announced that smallpox had been eradicated , the world is once again dealing with smallpox vaccines and treatments, this time aimed at mpox.

Vaccines 128

Vaccines 128

The FDA Law Blog

AUGUST 11, 2024

By Sarah Wicks & Dara Katcher Levy — FDA’s Office of Prescription Drug Promotion (OPDP) has issued two new Untitled Letters this summer after 5 months without any letter activity. The letters are vastly different from one another in subject matter, but together they make a cruel summer of OPDP enforcement against industry. [Editorial note – the Gen X’er included that link first – for the arguably more popular reference, read on.

FDA 59

FDA Labelling Communication 59

IDStewardship

AUGUST 11, 2024

In this article an antimicrobial stewardship pharmacist discusses how to convince physicians to change their antibiotic prescribing practices Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 12 August 2024 Antimicrobial stewardship is about promoting the safe and rational use of antimicrobial agents. This goal can be achieved in many ways, but a key part of the effort needs to be getting physicians on board with prescribing practices that the antimicrobial stewardship progr

Nursing Homes 130

Nursing Homes Communication Hospitals 130